Apyx Medical Corp financial data

Symbol
APYX on Nasdaq
Location
Clearwater, FL
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 10 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 489% % -11%
Quick Ratio 79% % -8.6%
Debt-to-equity 534% % 60%
Return On Equity -115% % 25%
Return On Assets -18% % 48%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 41,829,226 shares 11%
Common Stock, Shares, Outstanding 41,785,946 shares 11%
Entity Public Float $79,800,000 USD 85%
Common Stock, Value, Issued $42,000 USD 11%
Weighted Average Number of Shares Outstanding, Basic 41,095,000 shares 16%
Weighted Average Number of Shares Outstanding, Diluted 34,644,000 shares 0.12%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $52,844,000 USD 9.9%
Research and Development Expense $3,373,000 USD -34%
Operating Income (Loss) $6,446,000 USD 66%
Nonoperating Income (Expense) $4,389,000 USD 1.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $10,835,000 USD 54%
Income Tax Expense (Benefit) $270,000 USD 7.1%
Net Income (Loss) Attributable to Parent $11,211,000 USD 52%
Earnings Per Share, Basic -0.27 USD/shares 59%
Earnings Per Share, Diluted -0.82 USD/shares -74%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $31,740,000 USD -0%
Accounts Receivable, after Allowance for Credit Loss, Current $16,776,000 USD 8.4%
Inventory, Net $8,602,000 USD 14%
Assets, Current $58,471,000 USD 3.6%
Property, Plant and Equipment, Net $2,371,000 USD 19%
Operating Lease, Right-of-Use Asset $4,218,000 USD -10%
Other Assets, Noncurrent $1,752,000 USD 5.3%
Assets $66,840,000 USD 3.1%
Accounts Payable, Current $3,058,000 USD 17%
Employee-related Liabilities, Current $1,277,000 USD
Accrued Liabilities, Current $8,214,000 USD 6%
Contract with Customer, Liability, Current $515,000 USD -51%
Liabilities, Current $11,700,000 USD 9.1%
Contract with Customer, Liability, Noncurrent $1,050,000 USD -6.1%
Operating Lease, Liability, Noncurrent $4,051,000 USD -9.6%
Other Liabilities, Noncurrent $347,000 USD 34%
Liabilities $52,009,000 USD 3%
Retained Earnings (Accumulated Deficit) $89,122,000 USD -14%
Stockholders' Equity Attributable to Parent $14,540,000 USD 2.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $14,831,000 USD 3.5%
Liabilities and Equity $66,840,000 USD 3.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $702,000 USD 89%
Net Cash Provided by (Used in) Financing Activities $25,000 USD
Net Cash Provided by (Used in) Investing Activities $55,000 USD -57%
Common Stock, Shares Authorized 75,000,000 shares 0%
Common Stock, Shares, Issued 41,785,946 shares 11%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $730,000 USD 89%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $32,678,000 USD 77%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,145,000 USD -2.6%
Deferred Tax Assets, Valuation Allowance $22,126,000 USD 6.9%
Deferred Tax Assets, Gross $23,433,000 USD 6.2%
Operating Lease, Liability $4,458,000 USD -7.5%
Payments to Acquire Property, Plant, and Equipment $55,000 USD 57%
Lessee, Operating Lease, Liability, to be Paid $6,222,000 USD -11%
Property, Plant and Equipment, Gross $6,502,000 USD 22%
Operating Lease, Liability, Current $407,000 USD 21%
Lessee, Operating Lease, Liability, to be Paid, Year Two $868,000 USD 5.3%
Lessee, Operating Lease, Liability, to be Paid, Year One $839,000 USD 5.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.0867 pure 1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,764,000 USD -19%
Lessee, Operating Lease, Liability, to be Paid, Year Three $764,000 USD -10%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $794,000 USD 3.9%
Additional Paid in Capital $103,620,000 USD 13%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $138,000 USD -12%
Deferred Tax Assets, Net of Valuation Allowance $1,307,000 USD -3.8%
Share-based Payment Arrangement, Expense $2,001,000 USD -50%
Interest Expense $4,524,000 USD 479%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%